Congenital chylothorax

disease
On this page

Summary

Congenital chylothorax (MONDO:0011331) is a disease with 1 cohort gene and 1 clinical trial.

At a glance

  • Prevalence: 1-9 / 100 000 (Germany) [Orphanet-validated]
  • Cohort genes: 1
  • ClinVar variants: 3
  • Clinical trials: 1

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Prevalence at birth1-9 / 100 0004.17GermanyValidated

Identifiers

Disease identifiers

FieldValue
Canonical namecongenital chylothorax
Mondo IDMONDO:0011331
MeSHC535461
OMIM603523
Orphanet264688
DOIDDOID:0060646
ICD-11641475779
SNOMED CT233646003
UMLSC0340014
MedGen87398
GARD0010156
Is cancer (heuristic)no

Data availability: 3 ClinVar variants.

Disease family

Classification path: disease › human disease › disease by body system or component › respiratory system disorderlower respiratory tract disorderpleural disordercongenital chylothorax

Related subtypes (4): pleurisy, pneumothorax, pleural empyema, pleural neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

3 retrieved; paginated sample, class counts are floors:

3 uncertain significance

ClinVarVariant (HGVS)GeneClassificationReview
1285159NM_138295.5(PKD1L1):c.3845T>A (p.Val1282Glu)PKD1L1Uncertain significancecriteria provided, multiple submitters, no conflicts
3062363NM_138295.5(PKD1L1):c.1543G>A (p.Gly515Arg)PKD1L1Uncertain significancecriteria provided, single submitter
3062364NM_138295.5(PKD1L1):c.6549G>T (p.Gln2183His)PKD1L1Uncertain significancecriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 0 · Orphanet: 2 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
PKD1L1Orphanet:101063Situs inversus totalis
PKD1L1Orphanet:157769Situs ambiguus

Cohort genes → proteins

1 cohort genes, 1 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence1

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
PKD1L1HGNC:18053ENSG00000158683Q8TDX9Polycystin-1-like protein 1clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
PKD1L1Polycystin-1-like protein 1Component of a calcium-permeant ion channel formed by PKD1L2 and PKD1L1 in primary cilia, where it controls cilium calcium concentration, without affecting cytoplasmic calcium concentration, and regulates sonic hedgehog/SHH signaling and G…

Protein-family classification

Druggable: 1 · Difficult: 0 · Unknown: 0 · Druggable fraction: 1.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Antibody/Immunoglobulin129.2×0.034

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
PKD1L1Antibody/ImmunoglobulinyesPKD_dom, PLAT/LH2_dom, PKD/REJ-like

Expression context

Cohort genes with no expression data: 0.

1 cohort gene are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)1
unknown0

Top tissues across cohort

TissueCohort genes
apex of heart1
male germ line stem cell (sensu Vertebrata) in testis1
primordial germ cell in gonad1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
PKD1L1150tissue_specificmarkermale germ line stem cell (sensu Vertebrata) in testis, apex of heart, primordial germ cell in gonad

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
PKD1L1571

Structural data

PDB: 0 · AlphaFold-only: 1 · No structure: 0

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
PKD1L1Q8TDX9

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 0. Enrichment computed across 1 evidence-associated genes (0 with Reactome annotation).

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
detection of nodal flow15617.3×7e-04PKD1L1
detection of mechanical stimulus11203.7×0.001PKD1L1
left/right axis specification11203.7×0.001PKD1L1
cell-cell adhesion1101.5×0.010PKD1L1

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1

Druggability breadth: 0 of 1 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
PKD1L100

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Pharmacogenomics

Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug0
DDruggable family + AlphaFold only, no drug1PKD1L1
EDifficult family or no structure, no drug0

Undrugged target profiles

1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
PKD1L10

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00267345Not specifiedUNKNOWNMeasurement of Hormonal Concentration in Chylothorax Fluid in Infants With Congenital Chylothorax